← Back to headlines
Keros Therapeutics Director Bienaime Purchases $10,270 in Shares
A director at the biotechnology firm Keros Therapeutics has executed a new purchase of company stock, signaling internal confidence in the firm's pipeline.
3 Sept, 00:15 — 3 Sept, 00:15
Sources
Showing 1 of 1 sources
Related Stories
Markets Rally and Gold Rebounds as Fed Official Dampens September Rate Hike Expectations
21m ago
US Investigates Missile Strike That Hit Iranian Wedding
49m ago
Volkswagen Board Approves 100,000 Job Cuts in Major Global Restructuring
1h ago
Japan Household Spending Drops 3.6% in July for Eighth Consecutive Month
1h ago